Biotech firms the latest to respond to serenade by city’s bourse to raise capital in Hong Kong

“Biotech was chosen as the initial focus in widening market access for early stage companies as the sector tends to be strictly regulated under a regime that sets external milestones on development progress,” the HKEX said in response to queries by the South China Morning Post, adding that the …